Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
10 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Lifevantage Corporation’s names, not what it holds today.
Patents granted
10
10 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
13
since 2001, to Dec 31, 2025
Names they are printed under
3
a subsidiary, its own name
By yearGrantedApplications published
'07'08'09'11'12'13'14'15'16'18'21'22'24
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
Lifeline Nutraceuticals Corporation a subsidiary
US, as the owner printed on each patent
5 publishedLIFEVANTAGE CORPORATION its own name
US, as the owner printed on each patent
6 publishedLifeVantage Corporation its own name
named as the applicant on its applications, in US
2 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Nov 1, 2022 | 11,484,563 | Compositions and methods for activating cellular signaling pathways | Pharmaceuticals | LIFEVANTAGE CORPORATION |
| Feb 13, 2018 | 9,889,171 | Topical compositions and methods for reducing oxidative stress | Organic fine chemistry | LIFEVANTAGE CORPORATION |
| Mar 22, 2016 | 9,289,374 | Topical compositions and methods for reducing oxidative stress | Organic fine chemistry | LIFEVANTAGE CORPORATION |
| Feb 23, 2016 | 9,265,808 | Compositions for alleviating inflammation and oxidative stress in a mammal | Pharmaceuticals | Lifeline Nutraceuticals Corporation |
| May 7, 2013 | 8,435,574 | Compositions for alleviating inflammation and oxidative stress in a mammal | Pharmaceuticals | Lifeline Nutraceuticals Corporation |
| Jul 17, 2012 | 8,221,805 | Compositions for alleviating inflammation and oxidative stress in a mammal | Pharmaceuticals | Lifeline Nutraceuticals Corporation |
| Apr 12, 2011 | 7,923,045 | Compositions for alleviating inflammation and oxidative stress in a mammal | Pharmaceuticals | Lifeline Nutraceuticals Corporation |
| Aug 25, 2009 | 7,579,026 | Methods for enhancing antioxidant enzyme activity and reducing c-reactive protein levels | Pharmaceuticals | Lifeline Nutraceuticals Corporation |
| Jun 10, 2008 | 7,384,655 | Preparation of compositions to alleviate inflammation and oxidative stress in a mammal | Pharmaceuticals | Lifeline Nutraceuticals Corporation |
| Jul 10, 2007 | 7,241,461 | Compositions for alleviating inflammation and oxidative stress in a mammal | Pharmaceuticals | Lifeline Nutraceuticals Corporation |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 5, 2024 | 2024/0398693 | COMPOSITION AND METHODS FOR ACTIVATING CELLULAR SIGNALING GENES IN INNATE INFLAMMATORY PATHWAYS | Pharmaceuticals | LifeVantage Corporation |
| Jul 15, 2021 | 2021/0213095 | COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS | Pharmaceuticals | LIFEVANTAGE CORPORATION |
| Jul 15, 2021 | 2021/0213093 | COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS | Pharmaceuticals | LIFEVANTAGE CORPORATION |
| Jul 15, 2021 | 2021/0213092 | COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS | Pharmaceuticals | LIFEVANTAGE CORPORATION · patent 11,484,563 granted from it |
| Jul 15, 2021 | 2021/0213086 | COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS | Pharmaceuticals | LIFEVANTAGE CORPORATION |
| Jun 16, 2016 | 2016/0166626 | TOPICAL COMPOSITIONS AND METHODS FOR REDUCING OXIDATIVE STRESS | Organic fine chemistry | LifeVantage Corporation · patent 9,889,171 granted from it |
| Oct 29, 2015 | 2015/0306022 | TOPICAL COMPOSITIONS AND METHODS FOR REDUCING OXIDATIVE STRESS | Organic fine chemistry | LIFEVANTAGE CORPORATION · patent 9,289,374 granted from it |
| Oct 8, 2015 | 2015/0283193 | Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal | Pharmaceuticals | Lifeline Nutraceuticals Corporation · patent 9,265,808 granted from it |
| Sep 25, 2014 | 2014/0287071 | VETERINARY SUPPLEMENTS | Pharmaceuticals | LIFEVANTAGE CORPORATION |
| Sep 18, 2014 | 2014/0271944 | Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal | Pharmaceuticals | Lifeline Nutraceuticals Corporation · patent 9,265,808 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.